No black box warning on record for Avmapki Fakzynja Co-Pack

As of the latest FDA labeling reviewed, Avmapki Fakzynja Co-Pack (AVUTOMETINIB POTASSIUM AND DEFACTINIB HYDROCHLORIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Avmapki Fakzynja Co-Pack medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Ocular Toxicities: Ocular toxicities, including visual impairment and vitreoretinal disorders, occurred. Perform comprehensive ophthalmic evaluation at baseline, prior to cycle 2, every three cycles thereafter, and as clinically indicated. Withhold AVMAPKI FAKZYNJA CO-PACK for ocular toxicities until improvement at the same or reduced dose. Permanently discontinue AVMAPK

No black box warning on record for Avmapki Fakzynja Co-Pack

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Ocular Toxicities: Ocular toxicities, including visual impairment and vitreoretinal disorders, occurred. Perform comprehensive ophthalmic evaluation at baseline, prior to cycle 2, every three cycles thereafter, and as clinically indicated. Withhold AVMAPKI FAKZYNJA CO-PACK for ocular toxicities until improvement at the same or reduced dose. Permanently discontinue AVMAPK

Avmapki Fakzynja Co-Pack Black Box Warning

No black box warning on record for Avmapki Fakzynja Co-Pack

Other warnings & precautions

Avmapki Fakzynja Co-Pack Black Box Warning

No black box warning on record for Avmapki Fakzynja Co-Pack

Other warnings & precautions